Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Gaurav Syal"'
Publikováno v:
Digestive Diseases and Sciences. 68:404-413
Autor:
Gaurav Syal, Miles P. Sparrow, Fernando Velayos, Adam S. Cheifetz, Shane Devlin, Peter M. Irving, Gilaad G. Kaplan, Laura E. Raffals, Thomas Ullman, Krisztina B. Gecse, Phillip R. Fleshner, Amy L. Lightner, Corey A. Siegel, Gil Y. Melmed
Publikováno v:
Digestive diseases and sciences, 67(10), 4687-4694. Springer New York
Background and Aims: The treatment of chronic pouchitis remains a challenge due to the paucity of high-quality studies. We aimed to provide guidance for clinicians on the appropriateness of medical and surgical treatments in chronic pouchitis. Method
Autor:
Christopher V. Almario, Welmoed K. van Deen, Michelle Chen, Rebecca Gale, Stéphanie Sidorkiewicz, So Yung Choi, Nirupama Bonthala, Christina Ha, Gaurav Syal, Taylor Dupuy, Xiaoyu Liu, Gil Y. Melmed, Brennan M.R. Spiegel
Publikováno v:
The American journal of gastroenterology, 117(9), 1508-1518. Springer Nature
INTRODUCTION: To support shared decision-making (SDM) between patients and providers surrounding biologic treatments, we created IBD&me ( ibdandme.org )-a freely available, unbranded, interactive decision aid. We performed a multicenter comparative e
Autor:
Phillip Gu, Jiyu Luo, Jihoon Kim, Paulina Paul, Berkeley Limketkai, Jenny S. Sauk, Sunhee Park, Nimisha Parekh, Kai Zheng, Vivek Rudrapatna, Gaurav Syal, Christina Ha, Dermot P. McGovern, Gil Y. Melmed, Phillip Fleshner, Samuel Eisenstein, Sonia Ramamoorthy, Parambir S. Dulai, Brigid S. Boland, Eduardo Grunvald, Uma Mahadevan, Lucila Ohno-Machado, William J. Sandborn, Siddharth Singh
Publikováno v:
American Journal of Gastroenterology. 117:1639-1647
Obesity is variably associated with treatment response in biologic-treated patients with inflammatory bowel diseases (IBD). We evaluated the association between obesity and risk of hospitalization, surgery, or serious infections in patients with IBD
Publikováno v:
Diseases of the Colon & Rectum. 65:399-405
Total proctocolectomy with ileal pouch-anal anastomosis has become the standard procedure for patients with medically refractory ulcerative colitis, although a subset will develop de novo Crohn's disease.In this study, we investigated the association
Autor:
Stephan R. Targan, Phillip Fleshner, Gil Y. Melmed, James Mirocha, Dermot P.B. McGovern, Adam Truong, Karen Zaghiyan, Christina Ha, Gaurav Syal
Publikováno v:
Colorectal Dis
AIM Tumour necrosis factor inhibitors (TNFi) have revolutionized the management of moderate to severe ulcerative colitis (UC) since their approval for UC in 2005. However, many patients ultimately require surgery with ileal pouch-anal anastomosis (IP
Autor:
Siddharth Singh, Jihoon Kim, Jiyu Luo, Paulina Paul, Vivek Rudrapatna, Sunhee Park, Kai Zheng, Gaurav Syal, Christina Ha, Phillip Fleshner, Dermot McGovern, Jenny S. Sauk, Berkeley Limketkai, Parambir S. Dulai, Brigid S. Boland, Samuel Eisenstein, Sonia Ramamoorthy, Gil Melmed, Uma Mahadevan, William J. Sandborn, Lucila Ohno-Machado
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
We compared the safety and effectiveness of tumor necrosis factor α (TNF-α) antagonists vs vedolizumab vs ustekinumab in patients with Crohn's disease (CD) in a multicenter cohort (CA-IBD).We created an electronic health record-based cohort of adul
Autor:
Angela Mujukian, Gregory J. Botwin, Rashmi Kumar, Brigid Boland, Michael Chiorean, Erica R. Cohen, David Fudman, Jason Hou, Caroline Hwang, Mark Lazarev, Donald F. Lum, Mark C. Mattar, Ryan McConnell, Arthur Ostrov, Nimisha Parekh, Douglas C. Wolf, Younis Ziad, Bradley Morganstern, Arash Horizon, Keren L. Appel, Swamy Venuturupalli, Daniel J. Wallace, Sarah Glover, Christina Ha, Gaurav Syal, Andrea Banty, Shervin Rabizadeh, Edward J. Feldman, Susie K. Lee, Theodore Stein, Nancy Sun, Min Wu, Joseph Ebinger, Susan Cheng, Gil Melmed, Dermot McGovern, Jonathan Braun
Publikováno v:
American Journal of Gastroenterology. 116:S453-S455
Autor:
Nghia H. Nguyen, Jiyu Luo, Paulina Paul, Jihoon Kim, Gaurav Syal, Christina Ha, Vivek Rudrapatna, Sunhee Park, Nimisha Parekh, Kai Zheng, Jenny S. Sauk, Berkeley Limketkai, Phillip Fleshner, Samuel Eisenstein, Sonia Ramamoorthy, Gil Melmed, Parambir S. Dulai, Brigid S. Boland, Uma Mahadevan, William J. Sandborn, Lucila Ohno-Machado, Dermot McGovern, Siddharth Singh
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 21(1)
There are limited data on outcomes of biologic therapy in Hispanic patients with inflammatory bowel diseases (IBDs). We compared risk of hospitalization, surgery, and serious infections in Hispanic vs non-Hispanic patients with IBD in a multicenter,
Autor:
Gaurav Syal, Lori Robbins, Gil Y. Melmed, Christina Ha, Eric A. Vasiliauskas, Edward J. Feldman, Amir H. Kashani, Phillip Fleshner, Dermot P.B. McGovern, Nirupama Bonthala, Stephan R. Targan
Publikováno v:
Digestive Diseases and Sciences. 66:199-205
Infliximab rescue therapy is effective in patients with corticosteroid refractory acute severe ulcerative colitis, but predictors of response remain poorly understood. We aimed to identify predictors of colectomy in this high-risk patient population.